Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Ozempic Finger: Drugs That Cause It, Drugs That Treat It, and What Doctors Do Next

By
Published Updated Last reviewed
8 linked public sourcesEditorial, sourcing, and corrections policy

Key numbers

  • 14.9%Mean body weight loss on semaglutide versus placebo in the STEP 1 trialSource: pubmed.ncbi.nlm.nih.gov, as cited 2026-11-07
  • 2 mgHighest weekly Ozempic dose listed on its injection labelSource: dailymed.nlm.nih.gov, as cited 2026-11-07
  • 2.5 to 10 gDaily collagen hydrolysate dose used in most oral collagen skin trialsSource: pubmed.ncbi.nlm.nih.gov, as cited 2026-11-07

At a glance

  • What it describes / Loose or wrinkled hand skin noticed after rapid weight loss
  • Semaglutide's documented effect / Weight loss, not a skin reaction
  • Weight change, STEP 1 / -14.9% with semaglutide 2.4 mg vs -2.4% with placebo at 68 weeks [2]
  • Head-to-head trial / Tirzepatide -20.2% vs semaglutide -13.7% at 72 weeks [3]
  • Label reports involving skin / Alopecia and dysesthesia, frequency not estimable [1]
  • Ozempic's approved uses / Type 2 diabetes, cardiovascular risk, kidney outcomes; not weight loss [1]
  • Highest Ozempic dose / 2 mg weekly, below the 2.4 mg used in STEP 1 [1][2]

Does semaglutide cause ozempic finger?

Semaglutide produces substantial weight loss, and loose hand skin after weight loss is the complaint people call Ozempic finger. The trials cited on this page report weight and other measures, not hand skin.

In STEP 1, 1,961 adults with overweight or obesity and without diabetes were randomized to semaglutide 2.4 mg weekly or placebo for 68 weeks. The semaglutide group lost a mean 14.9% of body weight, compared with 2.4% on placebo [2]. In SURMOUNT-5, 751 adults with obesity were randomized to tirzepatide 10 or 15 mg or semaglutide 1.7 or 2.4 mg for 72 weeks; mean weight change was -20.2% with tirzepatide and -13.7% with semaglutide [3].

Which drug is actually involved

Ozempic is approved for type 2 diabetes: for glycemic control, for reducing major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and for reducing sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease [1]. Ozempic has no weight-loss indication [1].

STEP 1 studied semaglutide 2.4 mg weekly, while the Ozempic injection label lists a maximum dose of 2 mg weekly [2][1]. Semaglutide is also sold as Rybelsus and Ozempic tablets for type 2 diabetes [4].

What the semaglutide label does list

The Ozempic label lists alopecia (hair loss) and dysesthesia among postmarketing reports, and says frequency cannot be estimated from voluntary reports [1]. Loose hand skin is not among them. Dysesthesia means an abnormal skin sensation such as burning or pain from a light touch, which is a different complaint from a change in skin texture.

Nick Sterling, MD, PhD on the side effects of Ozempic and Wegovy

Nick Sterling argues that drugs like Ozempic and Wegovy have real downsides that are harder to measure than their benefits. Drawing on patients he has seen in the emergency department, he names nausea and vomiting as the most common problems, which can lead to dehydration and sometimes kidney injury. He also warns of starvation ketosis, muscle wasting when people skip strength training and enough protein, and low mood linked to a large calorie deficit. He stresses that none of this is medical advice and that people should consult their own physician.

Who is speaking?

Nick Sterling, MD, PhD. Clinician who sees patients in the emergency department, as described on the channel Background

Episode notes and full video

Is there a treatment for ozempic finger?

The semaglutide and tirzepatide trials above did not test any treatment for loose hand skin. The nearest published research is on skin elasticity in general. A 2019 systematic review of 11 randomized trials with 805 patients found that oral collagen improved skin elasticity, hydration and dermal collagen density; eight of the trials used collagen hydrolysate at 2.5 to 10 g a day for 8 to 24 weeks [5]. None of those trials involved semaglutide, and the authors called for further studies to determine optimal dosing [5].

Questions worth asking

Choose the questions you want to keep

What happens to weight after stopping

Weight regain is well documented. In an off-treatment extension of 327 STEP 1 participants, those on semaglutide had lost a mean 17.3% of body weight by week 68, regained 11.6 percentage points in the following year, and had a net loss of 5.6% at week 120, versus 0.1% for placebo [6]. In STEP 4, 803 adults were randomized after a 20-week run-in to continue semaglutide 2.4 mg or switch to placebo; from week 20 to week 68 weight changed by -7.9% on continued treatment and +6.9% on placebo [7].

Frequently asked questions

Is ozempic finger a real medical diagnosis?
It is a popular term for loose hand skin noticed after weight loss. The Ozempic label's common reactions are nausea, vomiting, diarrhea, abdominal pain and constipation, with alopecia and dysesthesia among postmarketing reports [1].
Does Ozempic itself cause ozempic finger?
Ozempic is approved for type 2 diabetes, cardiovascular risk reduction and kidney outcomes, and has no weight-loss indication [1]. The 14.9% mean weight loss in STEP 1 came from semaglutide 2.4 mg weekly [2], which is above the 2 mg weekly Ozempic maximum [1].
Which semaglutide side effects involve skin or sensation?
The Ozempic label lists alopecia (hair loss) and dysesthesia among postmarketing reports, where frequency cannot be estimated from voluntary reports [1]. Dysesthesia is an abnormal skin sensation such as burning or pain from light touch, which is not the same as loose skin.
Does stopping semaglutide reverse ozempic finger?
Stopping semaglutide was followed by weight regain. In the STEP 1 extension, semaglutide participants regained 11.6 of the 17.3 percentage points they had lost, for a net 5.6% loss a year later [6]. In STEP 4, weight rose 6.9% after switching to placebo versus a 7.9% fall on continued treatment [7]. These studies report weight, not hand skin, so they do not show whether stopping reverses Ozempic finger.
Do collagen supplements help loose hand skin?
The available evidence is for skin in general. A 2019 systematic review of 11 randomized trials with 805 patients found that oral collagen improved skin elasticity, hydration and dermal collagen density [5]. Those trials did not involve semaglutide.

What people actually ask

What are the potential side effects of using Ozempic for diabetes?

The Ozempic label lists alopecia (hair loss) and dysesthesia among postmarketing reports, with frequency not estimable from voluntary reports. Its common reactions are nausea, vomiting, diarrhea, abdominal pain and constipation. Dysesthesia is an abnormal skin sensation, such as burning or pain from a light touch.

What does "Ozempic hands" mean?

"Ozempic hands" is not defined separately in this text. It describes loose, wrinkled hand skin, the same complaint as Ozempic finger, noticed after rapid weight loss. The Ozempic label does not list loose hand skin as a reaction.

What disease is Ozempic linked to?

Ozempic is approved for type 2 diabetes: for glycemic control, for reducing major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and for reducing kidney outcomes in adults with type 2 diabetes and chronic kidney disease. It has no weight-loss indication.

References

  1. U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
  2. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Once-Weekly Semaglutide in Adults with Overweight or Obesity
  3. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025;393(1):26-36. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
  4. U.S. National Library of Medicine, DailyMed. Rybelsus and Ozempic tablets (Novo Nordisk) (oral semaglutide) prescribing information. Rybelsus and Ozempic tablets (Novo Nordisk) (oral semaglutide) label
  5. Choi FD, Sung CT, Juhasz ML, Mesinkovsk NA. Oral Collagen Supplementation: A Systematic Review of Dermatological Applications. J Drugs Dermatol. 2019;18(1):9-16. Oral Collagen Supplementation: A Systematic Review of Dermatological Applications
  6. Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
  7. Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial
  8. Nick Sterling, MD, PhD. Ozempic in the ER: Side Effects of GLP-1 Receptor Agonists. Accessed 2026-11-11.
Evidence overview for Ozempic Finger: Drugs That Cause It, Drugs That Treat It, and What Doctors Do Next